entity

Cholesterol 24-hydroxylase / brain cholesterol turnover

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Cholesterol 24-hydroxylase / brain cholesterol turnover: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
2Hypotheses
1Analyses
0Outgoing
1Incoming

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (1)

SourceRelationTypeStr
CYP46A1participates_ingene0.61

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
CYP46A1 Overexpression Gene Therapy 0.631 neurodegeneration Lipid raft composition changes in synapt
CYP46A1 Suppression for Tau-Mediated Neurodegeneration 0.494 neurodegeneration Lipid raft composition changes in synapt

Mentioning Analyses (1)

Scientific analyses that reference this entity

Lipid raft composition changes in synaptic neurodegeneration

neurodegeneration | 2026-04-01 | 12 hypotheses Top: 0.648

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] Zhang T, Xu D, Trefts E, Lv M, Inuzuka H Science 2023 1
TREM2, microglia, and Alzheimer's disease. [PMID:33516818] Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Mech Ageing Dev 2021 1
Complement and microglia mediate early synapse loss in Alzheimer mouse models. [PMID:27033548] Hong S, Beja-Glasser VF, Nfonoyim BM, Fr Science 2016 1
Potential Biological Processes Related to Brain SLC13A5 Across the Lifespan: Wei [PMID:41750164] Ferreira BK, Schuck PF, Ferreira GC, Fre Brain sciences 2026 0
How cytochrome P450 enzymes in humans are involved in Parkinson's disease: a lit [PMID:41730497] Ren B, Yan H, Han C, Sun S, Wang D, Xu Y Neuroscience 2026 0
Dysregulated Cholesterol Clearance via CYP46A1 Contributes to Cerebellar Sterol [PMID:41828569] Tapia PJ, Rivera BI, Espinoza CS, Stolze International journal of molec 2026 0
Efavirenz treatment improves retinal vaso-obliteration and pathological neovascu [PMID:41810243] Bailey B, Rudd Zhong Manis J, Seth G, Ra Frontiers in medicine 2026 0
Radiosynthesis and Evaluation of 18F‑Labeled Deuterated Radioligand for Positron [PMID:41704371] Li Y, Song Z, Shi H, Zhao T, Chen J, Zho ACS medicinal chemistry letter 2026 0
Streptozotocin and L-Buthionine-Sulfoximine Decrease Neuron Membrane Lipid Packi [PMID:40439741] Martins YA, Cardinali CAEF, Costa AP, To Neurotoxicity research 2025 0
Treatment with efavirenz extends survival in a Creutzfeldt-Jakob disease model b [PMID:40540390] ["Ali T", "Cashion J", "Hannaoui S", "Ah JCI insight 2025 0
The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkins [PMID:39964974] Dai L, Wang J, Meng L, Zhang X, Xiao T, PLoS biology 2025 0
Sterol imbalances and cholesterol-24-hydroxylase dysregulation is linked to the [PMID:40045480] Griffiths L, Hawkins K, Yutuc E, Angelin Brain pathology (Zurich, Switz 2025 0
Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington's dis [PMID:40859407] Parsai LH, Chali F, Subashi E, Zeitouny Acta neuropathologica communic 2025 0
Overexpression of cholesterol 24-hydroxylase CYP46A1 attenuates retinal dysfunct [PMID:40975483] Long Z, Zhang J, Feng J, He T Experimental eye research 2025 0
Cholesterol metabolic reprogramming mediates microglia-induced chronic neuroinfl [PMID:40987840] Zhao Q, Li J, Feng J, Wang X, Liu Y, Wan Nature metabolism 2025 0
Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperp [PMID:40653030] Giannelli S, Eroli F, Loera-Valencia R, Neurobiology of disease 2025 0
Mesenchymal stem cells overexpressing CYP46A1 inhibit lipopolysaccharide-induced [PMID:40609611] Shao Y, Ma B, Jin R, Kong N, Tang J, Li European journal of pharmacolo 2025 0
ABC Transporters, APOE, CYP46A1, and LRP1 Gene Polymorphisms as Markers of Demen [PMID:41226793] Machowska M, Leszek J, Rączy-Krzemianows International journal of molec 2025 0
Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hall [PMID:38142760] Nunes MJ, Carvalho AN, Reis J, Costa D, Biochimica et biophysica acta. 2024 0
CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition [PMID:38266095] Latorre-Leal M, Rodriguez-Rodriguez P, F Science advances 2024 0